Malondialdehyde-modified low-density lipoprotein is a useful marker to identify patients with vulnerable plaque.

@article{Tajika2012MalondialdehydemodifiedLL,
  title={Malondialdehyde-modified low-density lipoprotein is a useful marker to identify patients with vulnerable plaque.},
  author={Kenichiro Tajika and Kentaro Okamatsu and Masamichi Takano and Shigenobu Inami and Masanori Yamamoto and Daisuke Murakami and Nobuaki Kobayashi and Takayoshi Ohba and Noritake Hata and Yoshihiko Seino and Kyoichi Mizuno},
  journal={Circulation journal : official journal of the Japanese Circulation Society},
  year={2012},
  volume={76 9},
  pages={
          2211-7
        }
}
BACKGROUND The association between elevated malondialdehyde-modified low-density lipoprotein (MDA-LDL) and plaque instability in patients with coronary artery disease (CAD) is suspected but not established. The aim of the present study was therefore to investigate the association between serum MDA-LDL and plaque characteristics on angioscopy. METHODS AND RESULTS A total of 37 consecutive patients with CAD and single-vessel disease who underwent pre-interventional angioscopy, were studied… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 23 REFERENCES

Matrix metalloproteinase-9 for the earliest stage acute coronary syndrome.

  • Circulation journal : official journal of the Japanese Circulation Society
  • 2011